Neurobehavioral Toxicology: Neurological and Neuropsychological Perspectives, Volume III
Central Nervous System
- 648 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Neurobehavioral Toxicology: Neurological and Neuropsychological Perspectives, Volume III
Central Nervous System
About This Book
This is the final volume in a three-volume work that has addressed the scientific methodologies relevant to clinical neurobehavioral toxicology. Volume I focused on basic concepts and methodologies in Neurobehavioral Toxicology, with Volume II focusing on the peripheral nervous system. Volume III attends to what is known about industrial and environmental chemicals, medicines, and substances of abuse and how these agents affect the central nervous system. All substances have the capacity to be toxic, depending on factors that include the physical properties of the chemical or compound, organism related variables, or interaction between the two. These substances on the other hand and as a result of these same factors might be used therapeutically or even recreationally. The difference between medicine, recreational drug, or poison depends often on a careful balance between adverse and intended effects. How to determine that a specified substance has caused harm is emphasized in the present volume by way of case examples and discussion. Illnesses and behavioral variations that compete with toxicant-induced explanations for findings in a given case, as well as the various controversies that can arise around issues of diagnosis and causal determination, are treated comprehensively in this volume.
Frequently asked questions
Information
Contents of Volume I
1 INTRODUCTION TO NEUROBEHAVIORAL TOXICOLOGY | ||||
Introduction | ||||
Some conceptual considerations | ||||
Neurotransmission | ||||
Neurotransmission and disease | ||||
Neurotoxicity | ||||
Common clinical neurobehavioral toxicology issues | ||||
Case presentations | ||||
Patient with progressive dementia | ||||
Patient with depression and suspected dementia | ||||
Importance of context with regard to toxic exposure | ||||
Exposure to a neurotoxicant in the context of a terrorist act | ||||
Comments | ||||
2 CLASSIFICATION AND MANAGEMENT OF TOXICANT-RELATED INFORMATION | ||||
Introduction | ||||
Assessment and management of risk | ||||
Classification | ||||
Conclusion | ||||
3 CLINICAL AND CLINICAL RESEARCH CONSIDERATIONS | ||||
Introduction | ||||
Scientific method | ||||
Definition of the problem to be addressed | ||||
Hypothesis | ||||
Experiment | ||||
Analysis | ||||
Conclusions based on the scientific method | ||||
Special research considerations | ||||
Animal models | ||||
Additional issues related to sample selection | ||||
Protection of subjects and research | ||||
Bias | ||||
Masking and placebo controls | ||||
Evaluation of research claims regarding causality | ||||
Conclusion | ||||
4 CLINICAL APPROACHES | ||||
Introduction | ||||
Clinical neurology and clinical neuropsychology | ||||
The referral model | ||||
Managing the professional interaction | ||||
The clinical process | ||||
Some commonalities across fields | ||||
The need for objectivity | ||||
The need for an evidence-based approach to the clinical process | ||||
Some general clinical attribute... |
Table of contents
- Studies on Neuropsychology, Neurology and Cognition
- Contents
- Contents of Volume I
- Contents of Volume II
- About the Primary Authors
- Guest Contributors
- Acknowledgments
- Disclosures
- From the Series Editor
- Authorsā Preface to Volume III
- 15 Industrial and environmental agents
- 16 Medications and substances of abuse
- 17 Conditions associated with or sometimes mimic toxic-induced central nervous system disease
- 18 Consequences of an incomplete differential diagnosis
- 19 Issues and controversies involving the central nervous system evaluation
- Appendix
- Index